Veterinary Medicine Market (By Animal Type: Production, Companion; By Product: Biologics, Pharmaceuticals, Medicated Feed Additives; By Mode of Delivery: Oral, Parenteral, Others (Topical, carrier); By End-use: Reference Laboratories, Point-of-care testing/In-house testing, Veterinary Hospitals & Clinics, Others) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 20212030

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Mode of Delivery Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Veterinary Medicine Market, By Animal Type

7.1.  Veterinary Medicine Market, by Animal Type, 2021-2030

7.1.1.    Production

7.1.1.1.        Market Revenue and Forecast (2017-2030)

7.1.2.    Companion

7.1.2.1.        Market Revenue and Forecast (2017-2030)

Chapter 8.  Global Veterinary Medicine Market, By Product

8.1.  Veterinary Medicine Market, by Product, 2021-2030

8.1.1.    Biologics

8.1.1.1.        Market Revenue and Forecast (2017-2030)

8.1.2.    Pharmaceuticals

8.1.2.1.        Market Revenue and Forecast (2017-2030)

8.1.3.    Medicated Feed Additives

8.1.3.1.        Market Revenue and Forecast (2017-2030)

Chapter 9.  Global Veterinary Medicine Market, By Mode of Delivery

9.1.  Veterinary Medicine Market, by Mode of Delivery, 2021-2030

9.1.1.    Oral

9.1.1.1.        Market Revenue and Forecast (2017-2030)

9.1.2.    Parenteral

9.1.2.1.        Market Revenue and Forecast (2017-2030)

9.1.3.    Others (Topical, carrier)

9.1.3.1.        Market Revenue and Forecast (2017-2030)

Chapter 10.      Global Veterinary Medicine Market, By End-use

10.1.        Veterinary Medicine Market, by End-use, 2021-2030

10.1.1.  Reference Laboratories

10.1.1.1.      Market Revenue and Forecast (2017-2030)

10.1.2.  Point-of-care testing/In-house testing

10.1.2.1.      Market Revenue and Forecast (2017-2030)

10.1.3.  Veterinary Hospitals & Clinics

10.1.3.1.      Market Revenue and Forecast (2017-2030)

10.1.4.  Others

10.1.4.1.      Market Revenue and Forecast (2017-2030)

Chapter 11.      Global Veterinary Medicine Market, Regional Estimates and Trend Forecast

11.1.        North America

11.1.1.  Market Revenue and Forecast, by Animal Type (2017-2030)

11.1.2.  Market Revenue and Forecast, by Product (2017-2030)

11.1.3.  Market Revenue and Forecast, by Mode of Delivery (2017-2030)

11.1.4.  Market Revenue and Forecast, by End-use (2017-2030)

11.1.5.  U.S.

11.1.5.1.      Market Revenue and Forecast, by Animal Type (2017-2030)

11.1.5.2.      Market Revenue and Forecast, by Product (2017-2030)

11.1.5.3.      Market Revenue and Forecast, by Mode of Delivery (2017-2030)

11.1.5.4.      Market Revenue and Forecast, by End-use (2017-2030)

11.1.6.  Rest of North America

11.1.6.1.      Market Revenue and Forecast, by Animal Type (2017-2030)

11.1.6.2.      Market Revenue and Forecast, by Product (2017-2030)

11.1.6.3.      Market Revenue and Forecast, by Mode of Delivery (2017-2030)

11.1.6.4.      Market Revenue and Forecast, by End-use (2017-2030)

11.2.        Europe

11.2.1.  Market Revenue and Forecast, by Animal Type (2017-2030)

11.2.2.  Market Revenue and Forecast, by Product (2017-2030)

11.2.3.  Market Revenue and Forecast, by Mode of Delivery (2017-2030)

11.2.4.  Market Revenue and Forecast, by End-use (2017-2030)

11.2.5.  UK

11.2.5.1.      Market Revenue and Forecast, by Animal Type (2017-2030)

11.2.5.2.      Market Revenue and Forecast, by Product (2017-2030)

11.2.5.3.      Market Revenue and Forecast, by Mode of Delivery (2017-2030)

11.2.5.4.      Market Revenue and Forecast, by End-use (2017-2030)

11.2.6.  Germany

11.2.6.1.      Market Revenue and Forecast, by Animal Type (2017-2030)

11.2.6.2.      Market Revenue and Forecast, by Product (2017-2030)

11.2.6.3.      Market Revenue and Forecast, by Mode of Delivery (2017-2030)

11.2.6.4.      Market Revenue and Forecast, by End-use (2017-2030)

11.2.7.  France

11.2.7.1.      Market Revenue and Forecast, by Animal Type (2017-2030)

11.2.7.2.      Market Revenue and Forecast, by Product (2017-2030)

11.2.7.3.      Market Revenue and Forecast, by Mode of Delivery (2017-2030)

11.2.7.4.      Market Revenue and Forecast, by End-use (2017-2030)

11.2.8.  Rest of Europe

11.2.8.1.      Market Revenue and Forecast, by Animal Type (2017-2030)

11.2.8.2.      Market Revenue and Forecast, by Product (2017-2030)

11.2.8.3.      Market Revenue and Forecast, by Mode of Delivery (2017-2030)

11.2.8.4.      Market Revenue and Forecast, by End-use (2017-2030)

11.3.        APAC

11.3.1.  Market Revenue and Forecast, by Animal Type (2017-2030)

11.3.2.  Market Revenue and Forecast, by Product (2017-2030)

11.3.3.  Market Revenue and Forecast, by Mode of Delivery (2017-2030)

11.3.4.  Market Revenue and Forecast, by End-use (2017-2030)

11.3.5.  India

11.3.5.1.      Market Revenue and Forecast, by Animal Type (2017-2030)

11.3.5.2.      Market Revenue and Forecast, by Product (2017-2030)

11.3.5.3.      Market Revenue and Forecast, by Mode of Delivery (2017-2030)

11.3.5.4.      Market Revenue and Forecast, by End-use (2017-2030)

11.3.6.  China

11.3.6.1.      Market Revenue and Forecast, by Animal Type (2017-2030)

11.3.6.2.      Market Revenue and Forecast, by Product (2017-2030)

11.3.6.3.      Market Revenue and Forecast, by Mode of Delivery (2017-2030)

11.3.6.4.      Market Revenue and Forecast, by End-use (2017-2030)

11.3.7.  Japan

11.3.7.1.      Market Revenue and Forecast, by Animal Type (2017-2030)

11.3.7.2.      Market Revenue and Forecast, by Product (2017-2030)

11.3.7.3.      Market Revenue and Forecast, by Mode of Delivery (2017-2030)

11.3.7.4.      Market Revenue and Forecast, by End-use (2017-2030)

11.3.8.  Rest of APAC

11.3.8.1.      Market Revenue and Forecast, by Animal Type (2017-2030)

11.3.8.2.      Market Revenue and Forecast, by Product (2017-2030)

11.3.8.3.      Market Revenue and Forecast, by Mode of Delivery (2017-2030)

11.3.8.4.      Market Revenue and Forecast, by End-use (2017-2030)

11.4.        MEA

11.4.1.  Market Revenue and Forecast, by Animal Type (2017-2030)

11.4.2.  Market Revenue and Forecast, by Product (2017-2030)

11.4.3.  Market Revenue and Forecast, by Mode of Delivery (2017-2030)

11.4.4.  Market Revenue and Forecast, by End-use (2017-2030)

11.4.5.  GCC

11.4.5.1.      Market Revenue and Forecast, by Animal Type (2017-2030)

11.4.5.2.      Market Revenue and Forecast, by Product (2017-2030)

11.4.5.3.      Market Revenue and Forecast, by Mode of Delivery (2017-2030)

11.4.5.4.      Market Revenue and Forecast, by End-use (2017-2030)

11.4.6.  North Africa

11.4.6.1.      Market Revenue and Forecast, by Animal Type (2017-2030)

11.4.6.2.      Market Revenue and Forecast, by Product (2017-2030)

11.4.6.3.      Market Revenue and Forecast, by Mode of Delivery (2017-2030)

11.4.6.4.      Market Revenue and Forecast, by End-use (2017-2030)

11.4.7.  South Africa

11.4.7.1.      Market Revenue and Forecast, by Animal Type (2017-2030)

11.4.7.2.      Market Revenue and Forecast, by Product (2017-2030)

11.4.7.3.      Market Revenue and Forecast, by Mode of Delivery (2017-2030)

11.4.7.4.      Market Revenue and Forecast, by End-use (2017-2030)

11.4.8.  Rest of MEA

11.4.8.1.      Market Revenue and Forecast, by Animal Type (2017-2030)

11.4.8.2.      Market Revenue and Forecast, by Product (2017-2030)

11.4.8.3.      Market Revenue and Forecast, by Mode of Delivery (2017-2030)

11.4.8.4.      Market Revenue and Forecast, by End-use (2017-2030)

11.5.        Latin America

11.5.1.  Market Revenue and Forecast, by Animal Type (2017-2030)

11.5.2.  Market Revenue and Forecast, by Product (2017-2030)

11.5.3.  Market Revenue and Forecast, by Mode of Delivery (2017-2030)

11.5.4.  Market Revenue and Forecast, by End-use (2017-2030)

11.5.5.  Brazil

11.5.5.1.      Market Revenue and Forecast, by Animal Type (2017-2030)

11.5.5.2.      Market Revenue and Forecast, by Product (2017-2030)

11.5.5.3.      Market Revenue and Forecast, by Mode of Delivery (2017-2030)

11.5.5.4.      Market Revenue and Forecast, by End-use (2017-2030)

11.5.6.  Rest of LATAM

11.5.6.1.      Market Revenue and Forecast, by Animal Type (2017-2030)

11.5.6.2.      Market Revenue and Forecast, by Product (2017-2030)

11.5.6.3.      Market Revenue and Forecast, by Mode of Delivery (2017-2030)

11.5.6.4.      Market Revenue and Forecast, by End-use (2017-2030)

Chapter 12.  Company Profiles

12.1.              Merck Animal Health

12.1.1.  Company Overview

12.1.2.  Animal Type Offerings

12.1.3.  Financial Performance

12.1.4.  Recent Initiatives

12.2.              Ceva Sante Animale

12.2.1.  Company Overview

12.2.2.  Animal Type Offerings

12.2.3.  Financial Performance

12.2.4.  Recent Initiatives

12.3.              Vetoquinol S.A.

12.3.1.  Company Overview

12.3.2.  Animal Type Offerings

12.3.3.  Financial Performance

12.3.4.  Recent Initiatives

12.4.              Zoetis

12.4.1.  Company Overview

12.4.2.  Animal Type Offerings

12.4.3.  Financial Performance

12.4.4.  Recent Initiatives

12.5.              Boehringer Ingelheim GmbH

12.5.1.  Company Overview

12.5.2.  Animal Type Offerings

12.5.3.  Financial Performance

12.5.4.  Recent Initiatives

12.6.              Elanco

12.6.1.  Company Overview

12.6.2.  Animal Type Offerings

12.6.3.  Financial Performance

12.6.4.  Recent Initiatives

12.7.              Nutreco N.V.

12.7.1.  Company Overview

12.7.2.  Animal Type Offerings

12.7.3.  Financial Performance

12.7.4.  Recent Initiatives

12.8.              Virbac

12.8.1.  Company Overview

12.8.2.  Animal Type Offerings

12.8.3.  Financial Performance

12.8.4.  Recent Initiatives

12.9.              Kindred Biosciences, Inc.

12.9.1.  Company Overview

12.9.2.  Animal Type Offerings

12.9.3.  Financial Performance

12.9.4.  Recent Initiatives

12.10.           Biogenesis Bago

12.10.1.               Company Overview

12.10.2.               Animal Type Offerings

12.10.3.               Financial Performance

12.10.4.               Recent Initiatives

Chapter 13.  Research Methodology

13.1.              Primary Research

13.2.              Secondary Research

13.3.              Assumptions

Chapter 14.  Appendix

14.1.              About Us

14.2.              Glossary of Terms